This is the first update to the guidelines since 2016. It is meant to provide recommendations for the periendoscopic management of anticoagulant and antiplatelet drugs during acute gastrointestinal bleeding or the elective endoscopic period.
The new recommendations can be found here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.